US 9605055
Anti-CD100 antibodies and methods of using the same
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 9605055 (Anti-CD100 antibodies and methods of using the same) held by VACCINEX, INC. expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61K39/0001, A61K39/3955